Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease.
Orbach
Hedi
H
Department of Medicine and Rheumatology Unit, Bikur Cholim Hospital, Jerusalem, Israel.
Gilburd
Boriss
B
Brickman
Chaim M
CM
Gerli
Roberto
R
Shoenfeld
Yehuda
Y
D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D001323:Autoantibodies / Q000097:blood*; D002956:Citrulline / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods* / Q000592:standards; D000939:Epitopes / Q000235:genetics / Q000276:immunology; D000091344:Filaggrin Proteins; D015804:HLA-DR4 Antigen / Q000235:genetics / Q000276:immunology; D006720:Homozygote; D006801:Humans; D007381:Intermediate Filament Proteins / Q000276:immunology* / Q000378:metabolism; D011237:Predictive Value of Tests; D011379:Prognosis; D011498:Protein Precursors / Q000378:metabolism; D012217:Rheumatoid Factor / Q000097:blood; D012720:Severity of Illness Index; D013997:Time Factors
D001323:Autoantibodies; D000939:Epitopes; D000091344:Filaggrin Proteins; D015804:HLA-DR4 Antigen; D007381:Intermediate Filament Proteins; D011498:Protein Precursors; D002956:Citrulline; D012217:Rheumatoid Factor